Tirze-Pep 10 mg

Dragon Pharma presents Tirze-Pep 10 mg, a high-purity research peptide containing Tirzepatide. This innovative compound represents a significant advancement in the study of metabolic pathways, functioning as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Each 2 mL vial contains 10 mg of lyophilized powder, providing researchers with a potent and reliable tool for scientific investigation.

Mechanism of Action and Research Applications of Tirzepatide

Tirzepatide is a first-in-class synthetic peptide that simultaneously targets two key metabolic receptors. Its dual agonist activity leads to enhanced insulin secretion, suppressed glucagon release, slowed gastric emptying, and promotion of satiety. This multi-faceted mechanism makes it a highly valuable compound for studies in glucose homeostasis, energy intake, and body composition regulation.

Research published by the National Institutes of Health (NIH) highlights the significant potential of dual GIP and GLP-1 receptor agonism in metabolic research, demonstrating profound effects in clinical settings.

Lab Test Report

Key Areas of Research for Tirze-Pep

• Metabolic Syndrome Studies: Investigating the compound's effects on insulin sensitivity and glycemic control.
• Appetite Regulation & Energy Balance: Researching its impact on central nervous system pathways that control food intake and energy expenditure.
• Lipid Metabolism: Exploring its role in fat storage and mobilization processes.
• Weight Management Mechanisms: Studying the compound's potential to influence body mass and composition through multiple pathways.

Potential Research Stacks and Synergies

For comprehensive metabolic studies, researchers may consider combining Tirze-Pep with other compounds that target related pathways. The following Dragon Pharma products may be relevant for advanced research protocols:

• L-Carnitine 500 mg: To support the study of fatty acid oxidation and energy production alongside appetite regulation.
• Semaglutide: A GLP-1 receptor agonist for comparative studies on single versus dual agonism.
• NAD+ 500 mg: For research on cellular energy metabolism and its interaction with systemic metabolic regulators.
• Cardarine: A PPARδ agonist often researched for its effects on endurance and lipid metabolism, potentially synergistic with Tirzepatide's actions.
• Vitamin B Complex: Essential cofactors for metabolic enzymes, providing foundational support for any nutritional intervention study.

Research stacks should be designed based on a clear hypothesis and understanding of compound interactions.

Why Choose Dragon Pharma for Your Research Peptides?

Dragon Pharma is a trusted name in the research community, known for uncompromising quality and consistency. Our Tirze-Pep 10 mg is manufactured in state-of-the-art, certified facilities, ensuring you receive a product that meets the highest standards for peptide research. We provide detailed product information and support to the research community.

Frequently Asked Questions